Estabrook Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 181 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$44
-99.9%
140.0%0.00%
Q3 2022$69,000
+19.0%
140.0%0.00%
Q2 2022$58,000
-28.4%
140.0%0.00%
Q1 2022$81,000
-22.9%
140.0%0.00%
Q4 2021$105,000
-16.7%
140.0%0.00%
Q3 2021$126,000
-25.0%
140.0%0.00%
Q2 2021$168,000
-4.0%
140.0%0.00%
Q1 2021$175,000
-19.7%
140.0%0.00%
Q4 2020$218,000
+65.2%
140.0%0.00%
Q3 2020$132,000
+5.6%
140.0%0.00%
Q2 2020$125,000
+40.4%
140.0%0.00%
Q1 2020$89,000
-23.9%
140.0%0.00%
Q4 2019$117,000140.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 968,505$12,135,0001.23%
Golden State Equity Partners 126,608$1,586,0000.90%
McGuire Investment Group, LLC 272,801$3,418,0000.72%
Lombard Odier Asset Management (Switzerland) SA 848,429$10,631,0000.70%
Rhenman & Partners Asset Management AB 765,000$9,585,0000.67%
EMC Capital Management 72,061$903,0000.64%
WASATCH ADVISORS LP 10,328,423$129,415,0000.58%
Ceeto Capital Group, LLC 74,000$927,0000.45%
Fort Sheridan Advisors LLC 75,945$952,0000.38%
Vanguard Capital Wealth Advisors 34,580$388,679,0000.33%
View complete list of SANGAMO THERAPEUTICS INC shareholders